Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Discuss timing signals for reducing SP 500 in retirement portfolios, with risk considerations and withdrawal planning implications.
17,570 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
Bitcoin and Ethereum jumped after cooler-than-expected U.S. inflation data, while Japan’s Upper House committee advan...
Pet insurance stocks are among the year's standout performers in the broader insurance space. This review highlights ...
A Workday insider recently sold a sizable block of shares. This article breaks down what that signals for investors, ...
Onto Innovation is emerging as a leading semiconductor play for 2026, rooted in its metrology and advanced packaging ...
Rumors swirl about a $60.50 per share bid for PayPal by Stripe and Advent, with Block joining the mix. The real prize...
XRP holders can now earn yield from a native DeFi setup, as Flare and Xaman unveil a one-click integration. Two more ...
Space stocks remain volatile, but two names stand out for investors: SpaceX SPCX and Rocket Lab RKLB. This guide brea...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
A market-minded investor argues the reason keep buying amazon hinges on a massive, pre-contracted AWS backlog and a r...
A new survey of large U.S. companies finds finance leaders divided they'd on how to use tariff refunds, with only a m...